CPHI
Price
$1.74
Change
+$0.19 (+12.26%)
Updated
Jun 26 closing price
Capitalization
18.31M
SXTC
Price
$1.74
Change
+$0.02 (+1.16%)
Updated
Jun 26 closing price
Capitalization
950.1K
Interact to see
Advertisement

CPHI vs SXTC

Header iconCPHI vs SXTC Comparison
Open Charts CPHI vs SXTCBanner chart's image
China Pharma Holdings
Price$1.74
Change+$0.19 (+12.26%)
Volume$138.56K
Capitalization18.31M
China SXT Pharmaceuticals
Price$1.74
Change+$0.02 (+1.16%)
Volume$44K
Capitalization950.1K
CPHI vs SXTC Comparison Chart in %
Loading...
CPHI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CPHI vs. SXTC commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPHI is a Buy and SXTC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (CPHI: $1.74 vs. SXTC: $1.74)
Brand notoriety: CPHI and SXTC are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CPHI: 128% vs. SXTC: 1%
Market capitalization -- CPHI: $18.31M vs. SXTC: $950.1K
CPHI [@Pharmaceuticals: Other] is valued at $18.31M. SXTC’s [@Pharmaceuticals: Other] market capitalization is $950.1K. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPHI’s FA Score shows that 0 FA rating(s) are green whileSXTC’s FA Score has 0 green FA rating(s).

  • CPHI’s FA Score: 0 green, 5 red.
  • SXTC’s FA Score: 0 green, 5 red.
According to our system of comparison, CPHI is a better buy in the long-term than SXTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPHI’s TA Score shows that 5 TA indicator(s) are bullish while SXTC’s TA Score has 4 bullish TA indicator(s).

  • CPHI’s TA Score: 5 bullish, 4 bearish.
  • SXTC’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CPHI is a better buy in the short-term than SXTC.

Price Growth

CPHI (@Pharmaceuticals: Other) experienced а -2.47% price change this week, while SXTC (@Pharmaceuticals: Other) price change was -7.94% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.19%. For the same industry, the average monthly price growth was +14.45%, and the average quarterly price growth was +91.39%.

Reported Earning Dates

CPHI is expected to report earnings on Mar 31, 2025.

SXTC is expected to report earnings on Mar 28, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.19% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CPHI($18.3M) has a higher market cap than SXTC($950K). CPHI YTD gains are higher at: -25.333 vs. SXTC (-57.193). SXTC has less debt than CPHI: SXTC (3.76M) vs CPHI (5.39M).
CPHISXTCCPHI / SXTC
Capitalization18.3M950K1,926%
EBITDAN/A-5.36M-
Gain YTD-25.333-57.19344%
P/E RatioN/A0.03-
RevenueN/A1.97M-
Total CashN/AN/A-
Total Debt5.39M3.76M144%
FUNDAMENTALS RATINGS
CPHI vs SXTC: Fundamental Ratings
CPHI
SXTC
OUTLOOK RATING
1..100
6829
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
76
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9794
PRICE GROWTH RATING
1..100
9465
P/E GROWTH RATING
1..100
10085
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CPHI's Valuation (44) in the Pharmaceuticals Generic industry is in the same range as SXTC (76) in the Pharmaceuticals Major industry. This means that CPHI’s stock grew similarly to SXTC’s over the last 12 months.

CPHI's Profit vs Risk Rating (100) in the Pharmaceuticals Generic industry is in the same range as SXTC (100) in the Pharmaceuticals Major industry. This means that CPHI’s stock grew similarly to SXTC’s over the last 12 months.

SXTC's SMR Rating (94) in the Pharmaceuticals Major industry is in the same range as CPHI (97) in the Pharmaceuticals Generic industry. This means that SXTC’s stock grew similarly to CPHI’s over the last 12 months.

SXTC's Price Growth Rating (65) in the Pharmaceuticals Major industry is in the same range as CPHI (94) in the Pharmaceuticals Generic industry. This means that SXTC’s stock grew similarly to CPHI’s over the last 12 months.

SXTC's P/E Growth Rating (85) in the Pharmaceuticals Major industry is in the same range as CPHI (100) in the Pharmaceuticals Generic industry. This means that SXTC’s stock grew similarly to CPHI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CPHISXTC
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 12 days ago
82%
Bullish Trend 10 days ago
86%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CPHI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRFH2.930.40
+15.81%
Barfresh Food Group
CHMG48.922.05
+4.37%
Chemung Financial Corp
BRKL10.600.26
+2.51%
Brookline Bancorp
CXT55.580.90
+1.65%
Crane NXT Co
PTC169.540.94
+0.56%
PTC

CPHI and

Correlation & Price change

A.I.dvisor tells us that CPHI and TAK have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CPHI and TAK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPHI
1D Price
Change %
CPHI100%
+12.00%
TAK - CPHI
26%
Poorly correlated
-0.13%
HCM - CPHI
24%
Poorly correlated
-0.90%
SIGA - CPHI
23%
Poorly correlated
+1.86%
PAHC - CPHI
22%
Poorly correlated
+1.49%
SXTC - CPHI
22%
Poorly correlated
+1.16%
More

SXTC and

Correlation & Price change

A.I.dvisor tells us that SXTC and SNDL have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SXTC and SNDL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SXTC
1D Price
Change %
SXTC100%
+1.16%
SNDL - SXTC
28%
Poorly correlated
+2.46%
AYTU - SXTC
27%
Poorly correlated
-1.40%
CPHI - SXTC
24%
Poorly correlated
+12.00%
BHC - SXTC
22%
Poorly correlated
+3.39%
LNTH - SXTC
22%
Poorly correlated
+0.24%
More